Wall Street Zen Downgrades SBC Medical Group (NASDAQ:SBC) to Buy

SBC Medical Group (NASDAQ:SBC) was downgraded by investment analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Sunday, Wall Street Zen reports.

A number of other equities analysts have also issued reports on SBC. Weiss Ratings raised SBC Medical Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Tuesday, September 22nd. BTIG Research reissued a “buy” rating and set a $8.00 price target on shares of SBC Medical Group in a research report on Thursday, August 13th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $8.50.

SBC Medical Group Stock Up 2.7%

Shares of NASDAQ SBC opened at $5.03 on Friday. SBC Medical Group has a 1 year low of $2.78 and a 1 year high of $5.29. The firm has a market cap of $517.34 million, a price-to-earnings ratio of 10.70 and a beta of 0.63. The company has a debt-to-equity ratio of 0.09, a quick ratio of 3.27 and a current ratio of 3.31. The stock’s 50-day simple moving average is $3.88 and its 200-day simple moving average is $3.58.

SBC Medical Group (NASDAQ:SBC) last released its quarterly earnings results on Thursday, August 13th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.02). SBC Medical Group had a return on equity of 18.47% and a net margin of 27.99%.The business had revenue of $49.19 million during the quarter, compared to analyst estimates of $45.37 million. As a group, equities analysts anticipate that SBC Medical Group will post 0.44 earnings per share for the current fiscal year.

Hedge Funds Weigh In On SBC Medical Group

Hedge funds have recently bought and sold shares of the company. State Street Corp raised its holdings in shares of SBC Medical Group by 59.7% during the second quarter. State Street Corp now owns 49,239 shares of the company’s stock worth $152,000 after purchasing an additional 18,400 shares during the period. Citadel Advisors LLC bought a new stake in shares of SBC Medical Group during the 2nd quarter valued at about $446,000. Two Sigma Securities LLC acquired a new stake in SBC Medical Group during the second quarter worth about $66,000. Bank of America Corp DE acquired a new stake in SBC Medical Group during the second quarter worth about $35,000. Finally, BlackRock Inc. bought a new position in SBC Medical Group in the second quarter worth about $2,846,000. 60.82% of the stock is currently owned by institutional investors and hedge funds.

SBC Medical Group Company Profile

SBC Medical Group (NASDAQ: SBC) is a Japan-based medical services and management company focused primarily on the aesthetic medicine sector. Through its affiliated medical corporations and clinic network, the company supports the operation of facilities offering cosmetic surgery, cosmetic dermatology and related elective treatments.

The company provides a range of management and operational services to affiliated clinics, including branding and marketing, staff recruitment and training, purchasing, information technology, administrative support and business consulting.